Clinical Trials Browser

Terminated × NETWORK × Interventional × Clear all

NCT04221438 2026-03-12

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Phase 2 Terminated

3 enrolled 11 charts

Lymphatic Metastasis, Melanoma

NCT04438382 2026-02-27

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Phase 2 Terminated

1 enrolled 1 chart

Other hematologic neoplasm

Hematologic Neoplasms

NCT03904862 2025-10-30

Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery

Phase 1/2 Terminated

Microphthalmia, Isolated, with Coloboma 5, Medulloblastoma

NCT04402073 2025-10-23

PersoMed-I

Phase 2 Terminated

Medulloblastoma

NCT02863055 2025-09-19

NEMO

Phase 2 Terminated

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT04042051 2025-07-22

Panthera

Phase 1 Terminated

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT03153280 2025-07-08

Lithium

Phase 1 Terminated

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT03445000 2025-04-08

ALERT-lung

Phase 2 Terminated

14 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung

NCT03683277 2025-02-19

IFM2014-01

Phase 2 Terminated

Multiple Myeloma, Recurrence, Genetic Diseases, Inborn

NCT04150965 2025-02-14

Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT

Phase 1/2 Terminated

Multiple Myeloma, Recurrence

NCT04871529 2024-12-30

Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)

Phase 2 Terminated

6 enrolled 12 charts

Urinary Bladder Neoplasms

NCT03869762 2024-09-25

DICE

Phase 2 Terminated

Neoplasm Metastasis, Prostatic Neoplasms

NCT04908956 2024-06-28

STEREO

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT03887702 2024-05-20

Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors

Phase 3 Terminated

4 enrolled 5 charts

Hepatitis B

NCT03357224 2024-02-22

PARCT

Phase 2 Terminated

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT03461952 2024-02-22

NIMBLe

Phase 2 Terminated

4 enrolled 4 charts

Other solid neoplasm

Advanced Solid Tumors

NCT00930332 2024-02-12

Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain

Phase 1 Terminated

Nausea, Pain, Sleep Wake Disorders, Vomiting

NCT04274023 2024-02-01

ACCeSs

Phase 2 Terminated

Sarcoma, Clear Cell

NCT03412630 2023-11-24

Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

Phase NA Terminated

1 enrolled 1 chart

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04218825 2023-11-09

REACH

Phase 2 Terminated

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT04805203 2023-10-19

Covimmunomm

Phase NA Terminated

COVID-19, Multiple Myeloma

NCT02740920 2023-08-25

Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography Texture Analysis as a Predictive Biomarker

Phase 2 Terminated

9 enrolled 8 charts

Melanoma

NCT00499174 2023-08-23

Observation or Radical Treatment in Patients With Prostate Cancer

Phase NA Terminated

180 enrolled 9 charts

Prostatic Neoplasms

NCT01011478 2023-08-16

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Phase 3 Terminated

406 enrolled 14 charts

GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Colorectal Neoplasms, Adenomatous Polyps

NCT03229382 2023-08-16

OPERA-PLRG10

Phase 2 Terminated

Lymphoma, Mantle-Cell

NCT00352079 2023-08-04

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Phase 3 Terminated

Urinary Bladder Neoplasms

NCT00651326 2023-08-04

DART

Phase 3 Terminated

Prostatic Neoplasms

NCT00658593 2023-08-04

Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer

Phase 3 Terminated

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00303628 2023-07-06

Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer

Phase 3 Terminated

355 enrolled 11 charts

Gastrointestinal

Rectal Neoplasms

NCT00003910 2023-07-05

Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia

Phase 2 Terminated

59 enrolled 8 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Large Granular Lymphocytic

NCT00335140 2023-07-03

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

Phase 2 Terminated

26 enrolled 11 charts

Lymphoma

NCT00551759 2023-07-03

Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Phase 2 Terminated

22 enrolled 5 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT01390584 2023-06-29

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Phase 2 Terminated

6 enrolled 9 charts

Hodgkin Disease, Lymphoma

NCT02031536 2023-06-29

Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery

Phase 2 Terminated

2 enrolled 8 charts

Glucagonoma, Insulinoma, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

NCT00002525 2023-06-28

Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed

Phase 3 Terminated

859 enrolled 8 charts

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00057954 2023-06-28

Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma

Phase 2 Terminated

6 enrolled 7 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00104884 2023-06-28

FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma

Phase 2 Terminated

4 enrolled 4 charts

Melanoma

NCT01013961 2023-06-28

Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia

Phase 2 Terminated

31 enrolled 10 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01824823 2023-06-28

Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence

Phase 2 Terminated

3 enrolled 6 charts

Squamous Cell Carcinoma of Head and Neck

NCT04194528 2023-06-27

S1916 Digital Medicine Program for Pain Control in Cancer Patients

Phase NA Terminated

2 enrolled 5 charts

Neoplasm Metastasis

NCT00002668 2023-06-22

Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer

Phase NA Terminated

BreastGenitourinary

Breast Neoplasms, Pain, Prostatic Neoplasms

NCT00052884 2023-06-18

Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation

Phase 1 Terminated

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

NCT00946712 2023-05-23

S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

Phase 3 Terminated

1,333 enrolled 22 charts

Adenocarcinoma of Lung

NCT00802711 2023-04-06

3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer

Phase NA Terminated

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT02151019 2023-04-06

TRI-LARC

Phase 1/2 Terminated

Gastrointestinal

Locally Advanced Rectal Cancer

NCT02764086 2023-04-06

INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer

Phase 1/2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT01187810 2022-03-31

Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01553071 2022-03-31

Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies

Phase 1 Terminated

Neoplasms, Recurrence

NCT02163356 2022-03-31

SPOC2013-001

Phase 1 Terminated

Neuroblastoma, Recurrence

NCT02323659 2022-01-13

Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas

Phase 4 Terminated

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous